[EN] KV3 ENHANCERS FOR THE TREATMENT OF COGNITIVE DISORDERS<br/>[FR] ACTIVATEURS DE KV3 POUR LE TRAITEMENT DE TROUBLES COGNITIFS
申请人:HOFFMANN LA ROCHE
公开号:WO2021214090A1
公开(公告)日:2021-10-28
The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L, Y1 to Y4 and R1 to R6 are as described herein.